Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.
Tsukazaki Y, Ogino H, Okano Y, Kakiuchi S, Harada S, Toyoda Y, Matsumura Y, Ichihara S, Imakura T, Matsumoto R, Ozaki R, Ogawa E, Morita Y, Mitsuhashi A, Yabuki Y, Yoneda H, Hanibuchi M, Hase K, Takeuchi E, Haku T, Nishioka Y.
Tsukazaki Y, et al. Among authors: matsumura y.
Int J Clin Oncol. 2024 Oct;29(10):1451-1460. doi: 10.1007/s10147-024-02586-0. Epub 2024 Jul 15.
Int J Clin Oncol. 2024.
PMID: 39009900